Sidra Medicine appoints Chief Medical Officer and Chief Research Officer

Doha: Sidra Medicine has appointed Prof Ziyad M Hijazi as its Chief Medical Officer (CMO) and Dr Khalid Fakhro as its Chief Research Officer (CRO).

Dr Barbro Fridén, Chief Executive Officer at Sidra Medicine said: “We are pleased to appoint Prof. Hijazi and Dr. Fakhro in these two critical roles at Sidra Medicine. Both leaders have an unwavering commitment to advancing healthcare and with the support of all of us at Sidra Medicine, I hope our organization becomes the first choice for parents across the Middle East who are seeking personalized care for their children. I also hope that our precision medicine program, will set the clinical research framework for advancing academic medicine in this region.” Prof. Hijazi has nearly 40 years of experience in Congenital Cardiology and has pioneered several ground-breaking interventional procedures in the field. He is an internationally recognized leader in the nonsurgical repair of congenital and structural heart defects in children and adults and in the development of novel trans-catheter devices.